Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.
about
The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular CalcificationDevelopment and prevention of advanced diabetic nephropathy in RAGE-overexpressing miceAdvanced glycation: an important pathological event in diabetic and age related ocular diseaseOxidative stress and diabetic complicationsMolecular mechanisms of diabetic vascular complicationsDeletion of hemojuvelin, an iron-regulatory protein, in mice results in abnormal angiogenesis and vasculogenesis in retina along with reactive gliosis.Multiplex analysis of age-related protein and lipid modifications in human Bruch's membraneCandesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function.Comparison of serum glycosylated hemoglobin levels in patients with diabetic cystoid macular edema with and without serous macular detachment.Advanced glycation end products of bovine serum albumin-induced endothelial-to-mesenchymal transition in cultured human and monkey endothelial cells via protein kinase B signaling cascades.Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema.α-Melanocyte-stimulating hormone protects retinal vascular endothelial cells from oxidative stress and apoptosis in a rat model of diabetesOcular rigidity and outflow facility in nonproliferative diabetic retinopathyPericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier.Role of advanced glycation end products in cardiovascular disease.Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers.Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis.Alterations of retinal vasculature in cystathionine-Beta-synthase mutant mice, a model of hyperhomocysteinemiaAGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice.Diabetes downregulates large-conductance Ca2+-activated potassium beta 1 channel subunit in retinal arteriolar smooth muscleCellular signaling and potential new treatment targets in diabetic retinopathy.Oxidative stress in diabetes: implications for vascular and other complications.Advanced glycation end products increase retinal vascular endothelial growth factor expression.Deletion of thioredoxin-interacting protein preserves retinal neuronal function by preventing inflammation and vascular injury.Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis.Dietary hyperglycemia, glycemic index and metabolic retinal diseases.Diabetes-related adduct formation and retinopathy.Advanced glycation end products and diabetic retinopathy.Molecular mechanisms of diabetic retinopathy: potential therapeutic targets.Advanced glycation End-products (AGEs): an emerging concern for processed food industries.Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy.Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epitheliumInvolvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.Neurovascular protective effect of FeTPPs in N-methyl-D-aspartate model: similarities to diabetes.Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.Role of interleukin-1beta in the pathogenesis of diabetic retinopathy.Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression.
P2860
Q26740003-F26F77D3-876A-4C14-A504-15B28BCECF42Q28344139-A3282041-7CDE-4BCB-9798-CA0EF0F414B5Q28365776-9FB19CEE-BB05-4811-94BE-9B591A8212D5Q29615423-6DDC1C91-F8EB-4820-9E50-659B6592FCCEQ33558421-C00E644B-A01B-4C55-A7CD-79F6E71297D2Q33739124-F3E72B87-69D0-406D-8FE3-C7F357255032Q34352853-D6FD21CE-CAE9-4073-90E0-C9F05DF5C52DQ34355343-F00ACBB1-1BE5-49A6-896D-4B13FF0BB5F9Q34356158-0E1DD5A0-6ADF-4979-A94A-AD387E0E2261Q34410712-022BBC47-55FF-43F8-AC7A-130F4009C024Q34758061-EA827ACE-8D95-4D41-BAED-628D1E2E3755Q35138684-38428774-642B-4A2D-9C18-9FF80192413EQ35543684-835485E2-93B0-47D4-8ADB-89AF8A1EC13AQ35575592-1DD5964B-D4D1-4010-A99D-E7DE8BE431B4Q35929112-5AEBFC83-99C9-4F1C-BA1B-262F6C2DBD0DQ36384149-28B5DE79-DCC0-4DAE-AD0C-4C40844099B7Q36438245-2FB3C83A-3B7B-4875-B061-41019E0D613EQ36438378-05DBF431-3D74-4D21-AF73-A9D80B21D07FQ36587668-5B18DF9C-6E55-4AA7-81D4-E7A14C737D82Q36844673-0F672397-38EE-4D11-A9E3-8B641B0DCF94Q37000197-656A09A4-CFB7-47D5-A1BF-100326CBBC85Q37089750-E7DAC132-3CA8-45EC-B7D4-65A754B5273EQ37375332-FB38EB51-652F-4696-8573-F0798A1D4C45Q37379211-CE4FF1C1-A140-4E1A-9549-A4B3AE47A77BQ37635278-BDCC94A2-58EC-4C10-B553-3777383CE687Q37690997-3A75F635-931C-4E9C-864D-FB2770F67936Q37733102-1A7B3B98-5CEB-4EA2-855F-BCF1D7EBCFD4Q38070160-D39E2787-82C4-4314-A148-A3629ABA412EQ38193463-AB2B32C9-35C5-4BD9-AFAF-1CA59A51276BQ38463463-1F4298C2-4B33-4BE0-9994-0011D41C98EAQ38647079-6B3663D4-D929-445E-854F-0901E62C5F5AQ38806774-936F2734-328F-4548-8A05-A0DD89E1CA27Q40477757-72FB864E-9E50-49A7-A011-646DBEF2EC79Q41789363-46A7E8EB-7DEE-4C75-8D02-2795EEDC04C3Q42470643-3D95B3BC-D764-4CED-A840-7DD8FB5E064BQ42767408-E080984D-328C-4649-998B-E882E3287517Q43007582-A68895D4-809C-4757-8962-5C0773EB228EQ45151232-31593B6F-FDDD-4147-8E26-340608DF1B99Q52716248-68051B23-D8A4-4ABC-A4AB-16AF58E9C0D8
P2860
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Advanced glycation end product ...... betic and of AGE-infused rats.
@ast
Advanced glycation end product ...... betic and of AGE-infused rats.
@en
type
label
Advanced glycation end product ...... betic and of AGE-infused rats.
@ast
Advanced glycation end product ...... betic and of AGE-infused rats.
@en
prefLabel
Advanced glycation end product ...... betic and of AGE-infused rats.
@ast
Advanced glycation end product ...... betic and of AGE-infused rats.
@en
P2093
P2860
P1476
Advanced glycation end product ...... betic and of AGE-infused rats.
@en
P2093
P2860
P304
P407
P577
1997-02-01T00:00:00Z